Veracyte Inc
Ownership
Ownership Structure
Who owns Veracyte Inc (VCYT)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 99.4% of the shares are freely tradable; institutional investors hold 113.0%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 16.39 | 13,172,618 | +0.3 | 03/31/2026 |
| FMR Inc | 9.66 | 7,763,849 | +35.3 | 03/31/2026 |
| Artisan Partners Limited Partnership | 6.89 | 5,538,404 | +0.8 | 06/30/2026 |
| State Street Corp | 6.27 | 5,043,590 | +15.7 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 5.53 | 4,444,730 | +0.0 | 03/31/2026 |
| Vanguard Capital Management, LLC | 4.39 | 3,532,232 | +0.0 | 03/31/2026 |
| ARK Investment Management LLC | 3.80 | 3,053,818 | -21.4 | 03/31/2026 |
| Dimensional Fund Advisors, Inc. | 3.52 | 2,826,524 | -1.9 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 6.05 | 4,866,333 | +0.0 | 08/31/2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 3.16 | 2,541,476 | +0.3 | 07/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Stapley Marc | Chief Executive Officer | 432,073 | 17,542,164 $ | Sep 2, 2026 | direct |
| Chambers Rebecca | Chief Financial Officer | 166,025 | 6,740,615 $ | Sep 4, 2026 | direct |
| Febbo Phillip G. | Chief Scientific & Med Officer | 133,048 | 5,401,749 $ | Sep 4, 2026 | direct |
| McGuire Annie | EVP, General Counsel | 131,160 | 5,325,096 $ | Sep 4, 2026 | direct |
| Leite John | Global Chief Commercial Off | 128,344 | 5,210,766 $ | Sep 2, 2026 | direct |
| Wygant Jonathan | VP, Chief Accounting Officer | 43,226 | 1,754,976 $ | Sep 2, 2026 | direct |
| Bhanji Muna | Director | 42,718 | 1,734,351 $ | Sep 1, 2026 | direct |
| Holstein Jens | Director | 27,471 | 1,115,323 $ | Sep 14, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 14, 2026 | Holstein Jens | Director | Sell | 5,000 | 40.95 | 204,747 |
| Sep 4, 2026 | McGuire Annie | EVP, General Counsel | Sell | 1,100 | 43.67 | 48,039 |
| Sep 4, 2026 | McGuire Annie | EVP, General Counsel | Sell | 2,154 | 42.79 | 92,173 |
| Sep 4, 2026 | Chambers Rebecca | Chief Financial Officer | Sell | 1,175 | 43.71 | 51,364 |
| Sep 4, 2026 | Chambers Rebecca | Chief Financial Officer | Sell | 2,477 | 42.81 | 106,030 |
| Sep 4, 2026 | Febbo Phillip G. | Chief Scientific & Med Officer | Sell | 2,705 | 43.66 | 118,105 |
| Sep 4, 2026 | Febbo Phillip G. | Chief Scientific & Med Officer | Sell | 10,405 | 42.89 | 446,305 |
| Sep 2, 2026 | Leite John | Global Chief Commercial Off | Other | 3,961 | 44.88 | 177,770 |
| Sep 2, 2026 | McGuire Annie | EVP, General Counsel | Other | 3,215 | 44.88 | 144,289 |
| Sep 2, 2026 | Chambers Rebecca | Chief Financial Officer | Other | 3,603 | 44.88 | 161,703 |
| Sep 2, 2026 | Febbo Phillip G. | Chief Scientific & Med Officer | Other | 3,639 | 44.88 | 163,318 |
| Sep 2, 2026 | Wygant Jonathan | VP, Chief Accounting Officer | Other | 1,361 | 44.88 | 61,082 |
| Sep 2, 2026 | Stapley Marc | Chief Executive Officer | Other | 8,782 | 44.88 | 394,136 |
| Sep 1, 2026 | Bhanji Muna | Director | Sell | 1,864 | 42.97 | 80,096 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.